Please join our staff as we participate or present in the following oral and poster presentations at the 2017 ASCO Annual Meeting
Monday, June 5
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
7:30 AM – 9:15 AM
Location: Hall D1
HIGHLIGHTS OF THE DAY SESSION: Highlights of the Day Session II
7:30 AM – 7:50 AM
Central Nervous System Tumors
David M. Peereboom, MD – Discussant
8:00 AM – 9:15 AM
Location: S406
EDUCATION SESSION: Pancreatic Adenocarcinoma: Improving Prevention and Survivorship
Davendra Sohal, MD, MPH – Chair
8:00 AM – 8:20 AM
Best Practices in Management of Resectable Pancreatic Cancer: Emerging Standards for Adjuvant Therapy and Surveillance
Davendra Sohal, MD, MPH – Chair
8:00 AM – 9:15 AM
Location: E253cd
MEET THE PROFESSOR SESSION: Brain Metastases: Utilizing Genomics and Combining Treatment Modalities
8:00 AM – 8:20 AM
Innovative Targeted Therapeutic Approaches in Brain Metastases
Manmeet Singh Ahluwalia, MD – Speaker
8:00 AM – 11:30 AM
Location: Hall A
POSTER SESSION: Hematologic Malignancies — Leukemia, Myelodysplastic Syndromes, and Allotransplant
Abstract 7061: Phase I/II trial of glasdegib in patients with primary or secondary myelofibrosis
Poster Board: #261
Aaron Thomas Gerds, MS, MD – First Author
1:15 PM – 4:45 PM
Location: Hall A
POSTER SESSION: Central Nervous System Tumors
Abstract 2071: What drives patient outcomes in brain metastases: Number, volume, or biology?
Poster Board: #313
Rupesh Kotecha, MD – First Author
POSTER SESSION: Genitourinary (Prostate) Cancer
Abstract 5041: Clinical activity and safety of ASN001, a selective CYP17 lyase inhibitor, administered without prednisone in men with metastatic castration-resistant prostate cancer (mCRPC): A phase 1/2 clinical trial
Poster Board: #115
Jorge A. Garcia, MD – First Author
Advertisement
POSTER SESSION: Head and Neck Cancer
Abstract 6072: Prognostic factors associated with benefit to post-operative chemotherapy: A National Cancer Data Base analysis
Poster Board: #60
Jessica Lyn Geiger, MD – First Author
POSTER SESSION: Health Services Research, Clinical Informatics, and Quality of Care
Abstract 6557: Increase in time to initiating cancer therapy and association with worsened survival in curative settings: A U.S. analysis of common solid tumors
Poster Board: #379
Alok A. Khorana, MD – First Author
Abstract 6558: Minority patient reported attitudes regarding tissue donation and participation in cancer research
Poster Board: #380
Davendra Sohal, MD, MPH – First Author
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients